MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

MEK抑制剂TAK-733可降低细胞增殖，影响细胞周期和凋亡，并与其他靶向疗法在多发性骨髓瘤中发挥协同作用。